Introduction
What are risk factors?
Risk factors are characteristics that increase the chance of developing a disease or health condition.1 It is essential to understand risk factors to allow for the prevention, early detection, and management of conditions such as thrombosis.2,3
What is thrombosis?
Thrombosis is the formation of a thrombus (blood clot) within a blood vessel. A thrombus, made up of red blood cells, fibrin, and platelets, is formed in response to injury.5,6 Thrombosis is a serious condition because, depending on its level of obstruction, location, and movement, it can lead to life-threatening complications such as stroke and myocardial infarction.5
Types of thrombosis
Arterial thrombosis refers to the formation of blood clots in arteries, a type of blood vessel that carries oxygenated blood from the heart to the rest of the body. Venous thrombosis refers to the formation of blood clots in veins, a type of blood vessel that carries deoxygenated blood from the body to the heart.4
This article mentions venous thromboembolism. This term refers to the formation of blood clots within veins and affects 1 to 2 people per 1000 people each year, with two-thirds of all cases being deep vein thrombosis and one-third of cases being pulmonary embolism.28
Risk Factors for Thrombosis
Non-modifiable risk factors
Non-modifiable risk factors, such as genetics, age, and race, are risk factors that cannot be altered.
Genetic Factors
Inherited clotting disorders
Hemostasis is a highly coordinated process whereby the body repairs damaged blood vessels, forms blood clots, and maintains blood in a fluid state. Hemostasis involves the coagulation cascade, a complex series of events involving several enzymes and clotting factors (specific types of proteins) that enable blood to clot.7 Inherited clotting disorders are genetic conditions that affect the body’s ability to form blood clots.
Factor V is a clotting factor that plays a role in the coagulation cascade; however, a mutation in the F5 gene leads to Factor V Leiden, an inherited clotting disorder that increases hypercoagulability (the increased tendency of blood to clot), thereby increasing the risk of thrombosis and, subsequently, deep vein thrombosis.8,9
Prothrombin is another clotting factor involved in the coagulation cascade, which helps form blood clots. A prothrombin G20210A mutation leads to increased prothrombin levels and subsequently increased tendency to form blood clots and increased risk of venous thrombosis. 8,10
Anticoagulant deficiencies
Antithrombin, protein C, and protein S are natural anticoagulants, proteins which regulate hemostasis by inactivating clotting factors involved in the coagulation cascade.11 These anticoagulants limit the formation of blood clots to only the specific areas of damage, thereby preventing the formation of large clots that would occlude the blood vessel and limit the normal flow of blood.12
Mutations in the SERPINC1, PROC, and PROS1 genes lead to deficiencies in antithrombin, protein C, and protein S, respectively.8 While rare, anticoagulant deficiencies lead to thrombophilia, a condition in which the blood clots more easily, thus increasing the chance of thrombosis.8,12
Age
Venous thrombosis is rare in young people, with its incidence being less than one young person per 10,000 affected each year; however, the incidence of venous thrombosis increases with age by approximately 1% per year in the elderly.19
Sex
The incidence of thrombosis differs by sex. Men have a higher intrinsic risk of venous thromboembolism than women, regardless of age, with the age-adjusted incidence rate among men being 130 per 100,000 person-years compared to 100 per 100,000 person-years in women.20,21
That being said, oestrogen-containing contraception, hormone replacement therapy, gender‐affirming hormone therapy, and pregnancy also contribute to increased risk of venous and arterial thrombosis.21
Race
Compared to White populations, the risk of venous thromboembolism was 35% greater in Black populations, 30% lower in Hispanic populations, and 74% lower in Chinese populations.29 The racial difference in venous thromboembolism incidence could be due to racial differences in risk factors (such as obesity and inherited clotting disorders) prevalence.30
Lifestyle and Environmental Factors
Physical inactivity
A sedentary lifestyle, prolonged bed rest, and immobility can increase the risk of developing blood clots, also known as thrombosis. Muscle contraction in the lower extremities (from your hips to your toes) is needed to help blood flow back up to the heart. Physical inactivity and a lack of lower extremity muscle contraction could then lead to reduced blood flow, venous stasis, and accumulation of thrombin, which may overcome anticoagulant pathways and lead to thrombosis. .17,18
Obesity
Obesity refers to the excessive accumulation of fat. You are classed as obese if you have a body mass index (BMI) greater than 30 kg/m2. Compared to those with a normal BMI (18.5 to 24.9 kg/m2), obese people have a 2 to 5-fold increased risk of venous thromboembolism 13
Obesity can lead to insulin resistance and increased risk of diabetes; however, chronic inflammation and impaired fibrinolysis as a result of obesity have been identified as the mechanisms responsible for obesity-induced thrombosis.14
Smoking
Smoking, tobacco use, and second-hand exposure to tobacco smoke increase the risk of coronary thrombosis and venous thromboembolism by a number of mechanisms but chiefly through altering the function of endothelial cells, platelets, fibrinogen, and clotting factors.15,16
Medical Conditions
Cardiovascular disease
Cardiovascular diseases are a group of conditions that affect the heart and blood vessels. These conditions are often associated with atherosclerosis, the accumulation of fats on blood vessel walls, which develop into plaques that occlude the blood vessel. Inflammation and damage to the blood vessel can cause the plaque to rupture, exposing an area of damage that triggers the coagulation cascade to form a thrombus.33
Cancer
Cancer is a condition caused by the uncontrolled growth of abnormal cells. People who have cancer have a higher risk of developing blood clots due to a condition called cancer-associated thrombosis. Cancer patients have a higher incidence rate of arterial thrombosis (compared to matched controls), but venous thromboembolism is more common, affecting approximately 4% to 20% of cancer patients.22
The mechanism that causes cancer patients to be predisposed to thrombosis is not yet fully understood, but the presence of inflammatory cytokines and genetic changes influencing the coagulation cascade, prothrombotic chemotherapy drugs, and tumours damaging blood vessels are thought to promote a hypercoagulable state.22,23
Surgical and Trauma-Related Factors
Surgery
Postoperative thromboembolism is a serious complication of surgery with high incidence rates following total knee replacement, hip replacement, cardiac, and spine surgery.24 Deep vein thrombosis is another complication of surgery, which affects vascular and cardiac surgery patients more frequently than general surgery patients.25
Trauma or injury
Trauma refers to the sudden onset of severe tissue damage resulting from a blunt, penetrating or deceleration source of injury.
Patients with rib fractures are at higher risk of venous thromboembolism, with the risk increasing as the number of fractured ribs increases.26 Patients with pelvic, femoral, and tibial fractures are at higher risk of deep vein thrombosis.27
Traumatic rib, pelvic and lower-extremity fractures can lead to the development of thrombosis because of the hypercoagulable state, injury to blood vessels and reduced blood flow caused by the impact of the trauma, decreased mobility, and treatments such as sedative muscle relaxants, indwelling deep venous catheters.26,27
Infections
An infection is an illness caused by pathogens such as bacteria, viruses and fungi.
The main difference between infection-associated thrombosis and thrombosis associated with other episodes is the presence of a pathogen and its products, which promote inflammation. Inflammation, in turn, activates platelets and may also result in endothelial damage, fibrin deposition, and ultimately thrombus formation.31
FAQs
Is thrombosis dangerous?
Thrombosis can be dangerous because it has the potential to cause life-threatening conditions such as a stroke and heart attack if the thrombus becomes dislodged and blocks important blood vessels, such as the coronary arteries or cerebral arteries, which supply blood to the heart and brain, respectively.32
What are the signs of thrombosis?
The signs and symptoms of thrombosis depend on the severity and location of the thrombus. For example, deep vein thrombosis can cause the affected area (such as the leg) to look and feel swollen, red, warm and painful. Those with a pulmonary embolism typically present with shortness of breath, chest pain, back pain, and dizziness. Cardiac events due to arterial thrombosis, for example, in the coronary artery, can cause left-sided chest pain, which can spread to the jaw and left arm. Thrombosis in the cerebral arteries can cause symptoms such as headache, difficulty speaking, one-sided muscle weakness, confusion, and changes in vision.32
Can thrombosis be prevented?
By identifying risk factors relevant to you, you can make adjustments to your lifestyle to reduce the risk of developing thrombosis. Examples of lifestyle modifications include quitting smoking, increasing physical activity through exercise, and losing weight.32 Surgical patients may be given anticoagulant drugs and are advised to start walking early on following their surgical procedure to help prevent thrombosis.26 Your doctor may also advise you regarding your use of oral contraceptives.32
Summary
- Thrombosis refers to the formation of a thrombus (blood clot) within an arterial or venous blood vessel
- Risk factors are characteristics that increase your chance of developing a condition or disease
- Some risk factors of thrombosis are characteristics that you cannot change, such as increasing age, race, and genetics
- Other risk factors include physical inactivity, obesity, cardiovascular disease, surgery and infection
- Understanding of the mechanisms behind risk factors leading to thrombosis is evolving but fundamentally involves damage to blood vessels and changes in various components of the coagulation cascade
References
- Kirch W, editor. Risk FactorRisk factor(s). In: Encyclopedia of Public Health [Internet]. Dordrecht: Springer Netherlands; 2008 [cited 2025 Mar 21]; p. 1264–1264. Available from: https://doi.org/10.1007/978-1-4020-5614-7_3038.
- Davies S. Chief Medical Officer annual report 2011: the public’s health. Chapter 3 - Risk Factors. GOV.UK [Internet]. 2012. Available from: https://assets.publishing.service.gov.uk/media/5a7ab235e5274a34770e67b6/CMO_Annual_Report_2011_Chapter_3.pdf.
- Pencina MJ, Navar AM, Wojdyla D, Sanchez RJ, Khan I, Elassal J, et al. Quantifying Importance of Major Risk Factors for Coronary Heart Disease. Circulation [Internet]. 2019 [cited 2025 Mar 21]; 139(13):1603–11. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.031855.
- Lippi G, Favaloro E. Venous and Arterial Thromboses: Two Sides of the Same Coin? Semin Thromb Hemost [Internet]. 2018 [cited 2025 Mar 21]; 44(03):239–48. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1607202.
- Chernysh IN, Nagaswami C, Kosolapova S, Peshkova AD, Cuker A, Cines DB, et al. The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli. Sci Rep [Internet]. 2020 [cited 2025 Mar 21]; 10(1):5112. Available from: https://www.nature.com/articles/s41598-020-59526-x.
- Smith SA, Travers RJ, Morrissey JH. How it all starts: Initiation of the clotting cascade. Critical Reviews in Biochemistry and Molecular Biology [Internet]. 2015 [cited 2025 Mar 21]; 50(4):326–36. Available from: http://www.tandfonline.com/doi/full/10.3109/10409238.2015.1050550.
- Versteeg HH, Heemskerk JWM, Levi M, Reitsma PH. New Fundamentals in Hemostasis. Physiological Reviews [Internet]. 2013 [cited 2025 Mar 21]; 93(1):327–58. Available from: https://www.physiology.org/doi/10.1152/physrev.00016.2011.
- Zöller B, Svensson PJ, Dahlbäck B, Lind-Hallden C, Hallden C, Elf J. Genetic risk factors for venous thromboembolism. Expert Review of Hematology [Internet]. 2020 [cited 2025 Mar 21]; 13(9):971–81. Available from: https://www.tandfonline.com/doi/full/10.1080/17474086.2020.1804354.
- Ornstein DL, Cushman M. Factor V Leiden. Circulation [Internet]. 2003 [cited 2025 Mar 21]; 107(15). Available from: https://www.ahajournals.org/doi/10.1161/01.CIR.0000068167.08920.F1.
- Wolberg AS, Monroe DM, Roberts HR, Hoffman M. Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood [Internet]. 2003 [cited 2025 Mar 21]; 101(8):3008–13. Available from: https://ashpublications.org/blood/article/101/8/3008/16658/Elevated-prothrombin-results-in-clots-with-an.
- Maruyama K, Kokame K. Carrier frequencies of antithrombin, protein C, and protein S deficiency variants estimated using a public database and expression experiments. Research and Practice in Thrombosis and Haemostasis [Internet]. 2021 [cited 2025 Mar 21]; 5(1):179–86. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2475037922013073.
- Lipe B, Ornstein DL. Deficiencies of Natural Anticoagulants, Protein C, Protein S, and Antithrombin. Circulation [Internet]. 2011 [cited 2025 Mar 21]; 124(14). Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.111.044412.
- Hotoleanu C. Association between obesity and venous thromboembolism. Medicine and Pharmacy Reports [Internet]. 2020 [cited 2025 Mar 21]. Available from: https://medpharmareports.com/index.php/mpr/article/view/1372.
- Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity: Current Opinion in Hematology [Internet]. 2013 [cited 2025 Mar 21]; 20(5):437–44. Available from: http://journals.lww.com/00062752-201309000-00007.
- Barua RS, Ambrose JA. Mechanisms of Coronary Thrombosis in Cigarette Smoke Exposure. ATVB [Internet]. 2013 [cited 2025 Mar 21]; 33(7):1460–7. Available from: https://www.ahajournals.org/doi/10.1161/ATVBAHA.112.300154.
- Department of Anaesthesia and Intensive Care, Clinique Du Parc Saint Lazare, Beauvais, France, Al-Nasser B. Influence of Tobacco Smoking on Perioperative Risk of Venous Thromboembolism. Turk J Anaesthesiol Reanim [Internet]. 2020 [cited 2025 Mar 21]; 48(1):11–6. Available from: https://turkjanaesthesiolreanim.org/articles/doi/TJAR.2019.08683.
- Kabrhel C, Varraso R, Goldhaber SZ, Rimm E, Camargo CA. Physical inactivity and idiopathic pulmonary embolism in women: prospective study. BMJ [Internet]. 2011 [cited 2025 Mar 21]; 343(jul04 1):d3867–d3867. Available from: https://www.bmj.com/lookup/doi/10.1136/bmj.d3867.
- Mackman N. New insights into the mechanisms of venous thrombosis. J Clin Invest [Internet]. 2012 [cited 2025 Mar 21]; 122(7):2331–6. Available from: http://www.jci.org/articles/view/60229.
- Engbers MJ, Van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. Journal of Thrombosis and Haemostasis [Internet]. 2010 [cited 2025 Mar 21]; 8(10):2105–12. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1538783622115321.
- Crous-Bou M, Harrington L, Kabrhel C. Environmental and Genetic Risk Factors Associated with Venous Thromboembolism. Semin Thromb Hemost [Internet]. 2016 [cited 2025 Mar 21]; 42(08):808–20. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0036-1592333.
- Scheres LJJ, Van Hylckama Vlieg A, Cannegieter SC. Sex‐specific aspects of venous thromboembolism: What is new and what is next? Research and Practice in Thrombosis and Haemostasis [Internet]. 2022 [cited 2025 Mar 21]; 6(4):e12722. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2475037922012183.
- Abdol Razak N, Jones G, Bhandari M, Berndt M, Metharom P. Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment. Cancers [Internet]. 2018 [cited 2025 Mar 21]; 10(10):380. Available from: https://www.mdpi.com/2072-6694/10/10/380.
- Litt HK, Parks AL, Velazquez AI. Blood Clots, or Thrombosis, in Patients With Cancer. JAMA Oncol [Internet]. 2023 [cited 2025 Mar 21]; 9(6):876. Available from: https://jamanetwork.com/journals/jamaoncology/fullarticle/2803620.
- Kang K-W, Lee JY, Lee B-H, Jeon MJ, Yu ES, Kim DS, et al. Postoperative Thromboembolism According to the Type of Surgery: A Nationwide Study in the Republic of Korea. JCM [Internet]. 2022 [cited 2025 Mar 21]; 11(6):1477. Available from: https://www.mdpi.com/2077-0383/11/6/1477.
- Aziz F, Patel M, Ortenzi G, Reed AB. Incidence of Postoperative Deep Venous Thrombosis Is Higher among Cardiac and Vascular Surgery Patients as Compared with General Surgery Patients. Annals of Vascular Surgery [Internet]. 2015 [cited 2025 Mar 21]; 29(4):661–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0890509615000904.
- Zhang D, Yang Y, Yi Y, Wang D, Jiang L, Huang H, et al. Incidence and influence factors of venous thromboembolism in traumatic rib fracture patient: a multicenter study. J Orthop Surg Res [Internet]. 2024 [cited 2025 Mar 21]; 19(1):152. Available from: https://josr-online.biomedcentral.com/articles/10.1186/s13018-024-04622-1.
- Shi D, Bao B, Zheng X, Wei H, Zhu T, Zhang Y, et al. Risk factors for deep vein thrombosis in patients with pelvic or lower-extremity fractures in the emergency intensive care unit. Front Surg [Internet]. 2023 [cited 2025 Mar 21]; 10:1115920. Available from: https://www.frontiersin.org/articles/10.3389/fsurg.2023.1115920/full.
- Deep vein thrombosis: How common is it? NICE [Internet]. NICE Clinical Knowledge Summaries; 2025 [cited 2025 Mar 21]. Available from: https://cks.nice.org.uk/topics/deep-vein-thrombosis/background-information/incidence/.
- Weze KO, Obisesan OH, Dardari ZA, Cainzos-Achirica M, Dzaye O, Graham G, et al. The Interplay of Race/Ethnicity and Obesity on the Incidence of Venous Thromboembolism. American Journal of Preventive Medicine [Internet]. 2022 [cited 2025 Mar 21]; 63(1):e11–20. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0749379722000642.
- Zakai NA, McCLURE LA. Racial differences in venous thromboembolism. Journal of Thrombosis and Haemostasis [Internet]. 2011 [cited 2025 Mar 21]; 9(10):1877–82. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1538783622073652.
- Beristain-Covarrubias N, Perez-Toledo M, Thomas MR, Henderson IR, Watson SP, Cunningham AF. Understanding Infection-Induced Thrombosis: Lessons Learned From Animal Models. Front Immunol [Internet]. 2019 [cited 2025 Mar 21]; 10:2569. Available from: https://www.frontiersin.org/article/10.3389/fimmu.2019.02569/full.
- Ashorobi D, Ameer MA, Fernandez R. Thrombosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Mar 21]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK538430/.
- Palasubramaniam J, Wang X, Peter K. Myocardial Infarction—From Atherosclerosis to Thrombosis: Uncovering New Diagnostic and Therapeutic Approaches. ATVB [Internet]. 2019 [cited 2025 Mar 21]; 39(8). Available from: https://www.ahajournals.org/doi/10.1161/ATVBAHA.119.312578.

